肥胖女性孕前大幅减重对母婴健康影响的研究方案:一项随机对照试验
本研究为双臂平行随机对照试验,计划在墨尔本大学代谢疾病中心招募164名18-38岁、BMI 30-55 kg/m2、计划6-12个月内受孕的肥胖女性。受试者随机接受12周干预:A组通过低热量饮食实现适度减重(≤3%体重),B组通过改良极低能量饮食(VLED)实现大幅减重(10-15%体重),随后随访12个月。主要结局为妊娠26-28周母亲空腹血浆葡萄糖,次要结局包括受孕时间、活产率、妊娠期增重及母婴不良妊娠结局复合指标。
要点
- 肥胖女性孕前减重策略证据不足,减重手术对母婴结局影响不一。
- 本试验对比适度减重(≤3%)与大幅减重(10-15%)对妊娠结局的影响。
- 主要结局为妊娠26-28周母亲空腹血糖,随访12个月记录受孕及妊娠数据。
核心结论
- 本研究旨在确定孕前通过VLED实现大幅减重是否较标准护理改善母婴妊娠结局。
研究设计与样本
- 双臂平行随机对照试验,在墨尔本大学代谢疾病中心开展。
- 计划招募164名18-38岁、BMI 30-55 kg/m2、计划6-12个月内受孕的肥胖女性。
- 随机接受12周干预:A组适度减重(≤3%体重,低热量饮食),B组大幅减重(10-15%体重,改良VLED)。
- 所有参与者遵循NHMRC运动指南,并接受基于RANZCOG指南的标准孕前建议。
- 干预后随访12个月,若妊娠则记录母婴体重、代谢状态及妊娠结局。
关键数值与推荐
- 主要结局:妊娠26-28周母亲空腹血浆葡萄糖。
- 次要结局:受孕时间、活产率、妊娠期增重、母婴不良妊娠结局复合指标。
临床怎么用
- 为肥胖女性孕前减重策略提供随机对照证据,可能改变临床护理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current guidelines for the management of obesity in women planning pregnancy suggest lifestyle modification before conception. However, there is little evidence that lifestyle modification alters pregnancy outcomes. Bariatric surgery results in significant weight loss. This appears to reduce the risk of adverse pregnancy outcomes for the mother but may increase the risk of adverse outcomes for the infant. In order to reduce the risks of obesity-related adverse pregnancy outcomes for both mother and offspring, alternative approaches to the management of obesity in women planning pregnancy are needed. METHODS/DESIGN: This study, a two-arm, parallel group, randomized control trial, will be conducted at the Metabolic Disorders Centre, University of Melbourne. This trial will recruit 164 women aged 18-38 years with a body mass index of 30-55 kg/m2 who plan to conceive in the next 6-12 months. Women will be randomized to one of two 12-week interventions (Group A and Group B). Group A will aim for modest weight loss (MWL; ≤ 3% body weight) using a hypocaloric diet. Group B will aim for substantial weight loss (SWL; 10-15% body weight) using a modified very low energy diet (VLED) program. All participants will be asked to comply with National Health and Medical Research Council (NHMRC) guidelines for exercise and will be provided with standard pre-pregnancy advice according to Royal Australian and New Zealand College of Obstetrics and Gynaecology guidelines. All participants will then be observed for the subsequent 12 months. If pregnancy occurs within the 12-month follow-up period, data on weight and metabolic status of the mother, and pregnancy outcomes of mother and offspring will be recorded. The primary outcome is maternal fasting plasma glucose at 26-28 weeks' gestation, given that this is known to correlate with pregnancy outcomes. Time to conception, live birth rate, gestational weight gain, and a composite of adverse pregnancy outcomes for mother and baby will comprise the secondary outcomes. DISCUSSION: There is increasing emphasis on obese women losing weight before conception. To date, no randomized controlled trial has demonstrated an effective means of weight loss that results in improved pregnancy outcomes for both mother and baby. This study intends to determine if substantial pre-conception weight loss, achieved using a VLED, improves pregnancy outcomes for mother and baby when compared with standard care. This research will potentially change clinical care of an obese woman planning pregnancy. TRIAL REGISTRATION: ANZCTR, 12,614,001,160,628 . Registered on 5 November 2014.
引用
- Price S, Nankervis A, Permezel M, et al. Health consequences for mother and baby of substantial pre-conception weight loss in obese women: study protocol for a randomized controlled trial. Trials. 2018. PMID: 29690917. doi:10.1186/s13063-018-2615-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。